Automated Expansion of Primary Human T Cells in Scalable and Cell-Friendly Hydrogel Microtubes for Adoptive Immunotherapy

Haishuang Lin, Qiang Li, Ou Wang, Jack Rauch, Braden Harm, Hendrik J Viljoen, Chi Zhang, Erika Van Wyk, Chi Zhang, Yuguo Lei

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Adoptive immunotherapy is a highly effective strategy for treating many human cancers, such as melanoma, cervical cancer, lymphoma, and leukemia. Here, a novel cell culture technology is reported for expanding primary human T cells for adoptive immunotherapy. T cells are suspended and cultured in microscale alginate hydrogel tubes (AlgTubes) that are suspended in the cell culture medium in a culture vessel. The hydrogel tubes protect cells from hydrodynamic stresses and confine the cell mass less than 400 µm (in radial diameter) to ensure efficient mass transport, creating a cell-friendly microenvironment for growing T cells. This system is simple, scalable, highly efficient, defined, cost-effective, and compatible with current good manufacturing practices. Under optimized culture conditions, the AlgTubes enable culturing T cells with high cell viability, low DNA damage, high growth rate (≈320-fold expansion over 14 days), high purity (≈98% CD3+), and high yield (≈3.2 × 108 cells mL−1 hydrogel). All offer considerable advantages compared to current T cell culturing approaches. This new culture technology can significantly reduce the culture volume, time, and cost, while increasing the production.

Original languageEnglish (US)
Article number1701297
JournalAdvanced Healthcare Materials
Volume7
Issue number15
DOIs
StatePublished - Aug 8 2018

Fingerprint

Adoptive Immunotherapy
T-cells
Hydrogel
Cell culture
Hydrogels
T-Lymphocytes
Alginate
Cell Culture Techniques
Technology
Cellular Microenvironment
Costs and Cost Analysis
Hydrodynamics
Uterine Cervical Neoplasms
DNA Damage
Culture Media
Costs
Melanoma
Lymphoma
Cell Survival
Leukemia

Keywords

  • 3D cultures
  • T cells expansion
  • adoptive immunotherapy
  • alginate hydrogel tubes

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Pharmaceutical Science

Cite this

Automated Expansion of Primary Human T Cells in Scalable and Cell-Friendly Hydrogel Microtubes for Adoptive Immunotherapy. / Lin, Haishuang; Li, Qiang; Wang, Ou; Rauch, Jack; Harm, Braden; Viljoen, Hendrik J; Zhang, Chi; Van Wyk, Erika; Zhang, Chi; Lei, Yuguo.

In: Advanced Healthcare Materials, Vol. 7, No. 15, 1701297, 08.08.2018.

Research output: Contribution to journalArticle

@article{d201a2154a0049f4a1aef7b315f60637,
title = "Automated Expansion of Primary Human T Cells in Scalable and Cell-Friendly Hydrogel Microtubes for Adoptive Immunotherapy",
abstract = "Adoptive immunotherapy is a highly effective strategy for treating many human cancers, such as melanoma, cervical cancer, lymphoma, and leukemia. Here, a novel cell culture technology is reported for expanding primary human T cells for adoptive immunotherapy. T cells are suspended and cultured in microscale alginate hydrogel tubes (AlgTubes) that are suspended in the cell culture medium in a culture vessel. The hydrogel tubes protect cells from hydrodynamic stresses and confine the cell mass less than 400 µm (in radial diameter) to ensure efficient mass transport, creating a cell-friendly microenvironment for growing T cells. This system is simple, scalable, highly efficient, defined, cost-effective, and compatible with current good manufacturing practices. Under optimized culture conditions, the AlgTubes enable culturing T cells with high cell viability, low DNA damage, high growth rate (≈320-fold expansion over 14 days), high purity (≈98{\%} CD3+), and high yield (≈3.2 × 108 cells mL−1 hydrogel). All offer considerable advantages compared to current T cell culturing approaches. This new culture technology can significantly reduce the culture volume, time, and cost, while increasing the production.",
keywords = "3D cultures, T cells expansion, adoptive immunotherapy, alginate hydrogel tubes",
author = "Haishuang Lin and Qiang Li and Ou Wang and Jack Rauch and Braden Harm and Viljoen, {Hendrik J} and Chi Zhang and {Van Wyk}, Erika and Chi Zhang and Yuguo Lei",
year = "2018",
month = "8",
day = "8",
doi = "10.1002/adhm.201701297",
language = "English (US)",
volume = "7",
journal = "Advanced healthcare materials",
issn = "2192-2640",
publisher = "John Wiley and Sons Ltd",
number = "15",

}

TY - JOUR

T1 - Automated Expansion of Primary Human T Cells in Scalable and Cell-Friendly Hydrogel Microtubes for Adoptive Immunotherapy

AU - Lin, Haishuang

AU - Li, Qiang

AU - Wang, Ou

AU - Rauch, Jack

AU - Harm, Braden

AU - Viljoen, Hendrik J

AU - Zhang, Chi

AU - Van Wyk, Erika

AU - Zhang, Chi

AU - Lei, Yuguo

PY - 2018/8/8

Y1 - 2018/8/8

N2 - Adoptive immunotherapy is a highly effective strategy for treating many human cancers, such as melanoma, cervical cancer, lymphoma, and leukemia. Here, a novel cell culture technology is reported for expanding primary human T cells for adoptive immunotherapy. T cells are suspended and cultured in microscale alginate hydrogel tubes (AlgTubes) that are suspended in the cell culture medium in a culture vessel. The hydrogel tubes protect cells from hydrodynamic stresses and confine the cell mass less than 400 µm (in radial diameter) to ensure efficient mass transport, creating a cell-friendly microenvironment for growing T cells. This system is simple, scalable, highly efficient, defined, cost-effective, and compatible with current good manufacturing practices. Under optimized culture conditions, the AlgTubes enable culturing T cells with high cell viability, low DNA damage, high growth rate (≈320-fold expansion over 14 days), high purity (≈98% CD3+), and high yield (≈3.2 × 108 cells mL−1 hydrogel). All offer considerable advantages compared to current T cell culturing approaches. This new culture technology can significantly reduce the culture volume, time, and cost, while increasing the production.

AB - Adoptive immunotherapy is a highly effective strategy for treating many human cancers, such as melanoma, cervical cancer, lymphoma, and leukemia. Here, a novel cell culture technology is reported for expanding primary human T cells for adoptive immunotherapy. T cells are suspended and cultured in microscale alginate hydrogel tubes (AlgTubes) that are suspended in the cell culture medium in a culture vessel. The hydrogel tubes protect cells from hydrodynamic stresses and confine the cell mass less than 400 µm (in radial diameter) to ensure efficient mass transport, creating a cell-friendly microenvironment for growing T cells. This system is simple, scalable, highly efficient, defined, cost-effective, and compatible with current good manufacturing practices. Under optimized culture conditions, the AlgTubes enable culturing T cells with high cell viability, low DNA damage, high growth rate (≈320-fold expansion over 14 days), high purity (≈98% CD3+), and high yield (≈3.2 × 108 cells mL−1 hydrogel). All offer considerable advantages compared to current T cell culturing approaches. This new culture technology can significantly reduce the culture volume, time, and cost, while increasing the production.

KW - 3D cultures

KW - T cells expansion

KW - adoptive immunotherapy

KW - alginate hydrogel tubes

UR - http://www.scopus.com/inward/record.url?scp=85046813730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046813730&partnerID=8YFLogxK

U2 - 10.1002/adhm.201701297

DO - 10.1002/adhm.201701297

M3 - Article

C2 - 29749707

AN - SCOPUS:85046813730

VL - 7

JO - Advanced healthcare materials

JF - Advanced healthcare materials

SN - 2192-2640

IS - 15

M1 - 1701297

ER -